Sign in
ABPWW Stock Price, Chart, Stats & News
Abpro Holdings Inc
Save
Abpro Holdings Inc (ABPWW) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
ABPWW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -55.19% |
Operating margin | -7950.82% |
Pretax margin | -7702.19% |
Net margin | -7670.49% |
Effective tax rate | 0.41% |
ROA | -824.25% |
ROE | 83.19% |
D/E | -0.01x |
Interest coverage ratio | -12.28x |
ABPWW valuation
P/E | – |
P/S | 1.91x |
P/B | -0.02x |
P/CF | -0.02x |
P/FCF | -0.03x |
P/OCF | -0.02x |
PEG | -0.01x |
EV multiple | -0.04x |
About
Abpro Holdings Inc. is a biotechnology firm dedicated to creating sophisticated antibody-based treatments for individuals grappling with immuno-oncology, ophthalmology, and autoimmune disorders. The company's innovative DiversImmune platform is specifically engineered to resolve a key hurdle currently facing the antibody therapeutics sector. Among its leading experimental therapies are ABP-100, designed to combat breast, gastric, and colorectal cancers, and ABP-201, aimed at treating vascular conditions affecting the eye.
Similar securities
Based on sector and market capitalization
Report issue